Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | CA9 | Q16790 | 3/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.66 |
| ▸ | CA1 | P00915 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.59 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.55 |
| ▸ | S100A4 | P26447 | 2/20 | 0.53 |
| ▸ | PTPRC | P08575 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.48 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31259847 | 1.00 | KDM4E (0.71) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL11308425 | 0.87 | KDM4E (0.62) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL11309121 | 0.87 | KDM4E (0.62) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL4230682 | 0.86 | CA9 (0.60) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL9806781 | 0.86 | LMNA (0.81) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL11402428 | 0.85 | KDM4E (0.61) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL9502422 | 0.85 | KDM4E (0.61) | KDM4ECA2CA9CA12CA1 | |
| Hydrochloric Acid SCHEMBL11406824 | 0.85 | KDM4E (0.61) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL11312354 | 0.84 | CA2 (0.66) | KDM4ECA2CA9CA12CA1 | |
| SCHEMBL4231252 | 0.84 | TYMS (0.65) | KDM4ECA2CA9CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-108117505-A | A kind of preparation method for synthesizing diphenyl ether imidodicarbonic diamide | 杜庶铭 | 2018-06-05 | — | — | CN | claimed |
| CN-103497337-B | A kind of preparation method of Polythioetherimide | NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES (CN) | 2015-11-18 | — | — | CN | claimed |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | claimed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | claimed |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-10 | — | — | US | claimed |
| EP-1538138-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2005-06-08 | — | — | EP | claimed |
| US-5208346-A | Simplified process for the preparation of aromatic bismides | GENERAL ELECTRIC COMPANY (US) | 1993-05-04 | — | — | US | claimed |
| US-4054584-A | ALKALI METAL SULFIDES | GENERAL ELECTRIC COMPANY (US) | 1977-10-18 | — | — | US | claimed |
| US-3957862-A | FROM A NITRO-PHTHALIMIDE AND ALKALI DIPHENOXIDE | GENERAL ELECTRIC COMPANY (US) | 1976-05-18 | — | — | US | claimed |
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-110483454-B | Preparation method of aromatic diether dianhydride | 湖南师范大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-110483454-A | A kind of preparation method of two ether dianhydride of aromatic series | UNIV HUNAN NORMAL | 2019-11-22 | — | — | CN | disclosed |
| CN-108117505-A | A kind of preparation method for synthesizing diphenyl ether imidodicarbonic diamide | 杜庶铭 | 2018-06-05 | — | — | CN | disclosed |
| CN-103497337-B | A kind of preparation method of Polythioetherimide | NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES (CN) | 2015-11-18 | — | — | CN | disclosed |
| US-4011198-A | METHOD FOR MAKING POLYETHERIMIDES | GENERAL ELECTRIC COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3989712-A | Thio-bis(phthalimides) | GENERAL ELECTRIC COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
| US-3957862-A | FROM A NITRO-PHTHALIMIDE AND ALKALI DIPHENOXIDE | GENERAL ELECTRIC COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
| US-3956320-A | FIREPROOFING | GENERAL ELECTRIC COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| US-3933862-A | Aromatic dithio dianhydrides | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | KDM4E 2403/4885CA2 144/4885CA9 1605/4885 |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | GCN1, L3MBTL3, L3MBTL4 | KDM4E 3386/4885CA2 249/4885CA9 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.